MedPlus Health Services Limited has informed stock exchanges about a regulatory action affecting its subsidiary operations. The company disclosed that Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, has received a suspension order for a drug license of a store located in Maharashtra.

Regulatory Action Details

The suspension order was issued by the Assistant Commissioner Licensing Authority, Food Drug Administrations, Ahmednagar, Maharashtra. The order affects a store situated at Bhandari Colony, Ahmednagar, Maharashtra, and imposes a ten-day suspension of the drug license.

Financial Impact

The company has quantified the potential financial impact of this regulatory action. MedPlus Health Services estimates a potential revenue loss of ₹2.00 lakhs due to the ten-day suspension of the drug license for the affected store.

Compliance Disclosure

This disclosure was made pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, read with SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The company has informed both BSE Limited and National Stock Exchange of India Limited about this regulatory development as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Detailed information regarding this matter will be available on the company's website at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Limited.

MedPlus Health Services Limited's promoter entity has pledged additional shares worth ₹388.89 crores as part of its ongoing debt refinancing initiative. The company disclosed this development under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, providing detailed information about the share encumbrance arrangement.

Latest Share Pledging Details

Agilemed Investments Private Limited, the promoter entity, has pledged 48,51,066 equity shares of MedPlus Health Services Limited. The pledging was executed in favor of Catalyst Trusteeship Limited as the debenture trustee.

Promoter Group Shareholding Structure

The total promoter shareholding in MedPlus Health Services Limited stands at 4,82,80,627 shares, representing 40.29% of the total share capital. The encumbrance affects a significant portion of the promoter holdings across multiple entities.

Debt Refinancing Framework

The share pledging forms part of a comprehensive debt refinancing structure involving non-convertible debentures (NCDs) worth up to ₹175 crores. The arrangement includes specific financial terms designed to optimize the company's debt profile.

Pledge Dynamics and Timeline

The refinancing transaction involves temporary changes to the promoter group's share pledge arrangements. The incremental pledge is proposed in connection with refinancing existing debt through NCD issuance.

During the refinancing transaction and interim period, the pledge dynamics will evolve as follows:

• Current aggregate pledge level: 23.91% of total shares
• Temporary increase during refinancing: 27.96% of total shares
• Expected final level post-refinancing: 24.48% of total shares

The aggregate promoter group share pledge is expected to reduce to 24.48% upon successful completion of debt refinancing and consequent release of existing pledged shares by the current lender, following receipt of payment according to agreed terms.

Regulatory Compliance and Disclosure

The company has fulfilled its disclosure obligations under SEBI regulations, providing comprehensive details about the encumbrance arrangement. The disclosure covers all aspects required under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The borrowed funds will be utilized to retire existing non-convertible debentures issued by Agilemed Investments Private Limited, forming part of the overall debt optimization strategy for the promoter group entities.